ReviewPublished 12 October 2026CAR-T-cell therapy for autoimmune neurologic diseasesYunhan Zhao · Yunyu Ding · Congfeng Tang · Zhengrong Wei · Yuqing Fan · Xianhui Hu · Jilong YiFrontiers in Immunologydoi 10.3389/fimmu.2026.1942249
ReviewPublished 9 October 2026Polyclonal IgG therapy in neurologic and neuromuscular disease: mechanisms of action and insights from newer therapiesMel BergerFrontiers in Neurologydoi 10.3389/fneur.2026.1819474
Case ReportPublished 4 September 2026Case Report: Pembrolizumab–induced myasthenia gravis with isolated anti-titin antibody positivity after thymectomy for thymomaJu Hye Kim · Ji Yeon Chung · Jeong Bin BongFrontiers in Drug Discoverydoi 10.3389/fddsv.2026.1932554
